NCT00040001已完成2 期
Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation
Aderis Pharmaceuticals1 个研究点 分布在 1 个国家开始时间: 2002年6月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 1
研究概览
简要总结
This study is designed to evaluate the safety of DTI-0009 in patients with atrial fibrillation and to find the dose of DTI-0009 that lowers heart rates in patients with atrial fibrillation with rapid ventricular response.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Primary diagnosis of atrial fibrillation with rapid ventricular response of any duration as documented by an ECG
排除标准
- •Presence of other significant cardiac disease or history of significant neurological, hepatic,cardiovascular, renal, gastrointestinal, thyroid, respiratory, rheumatologic, or hematologic disease or impairment that in the investigator's judgment is serious enough to preclude the patient from safely participating in the study
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical CarcinomaAdrenal CancerACCAdrenocortical CarcinomaNCT01898715Millendo Therapeutics, Inc.63
已完成
1 期
Safety and efficay assessment of adenosine A2A receptor ligand [C-11]Preladenant in healthy volunteers.Healthy volunteerJPRN-UMIN000019999Tokoyo Metropolitan Institute of Gerontology15
Unknown
4 期
Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency AblationAtrial FibrillationNCT04209959Second Affiliated Hospital of Nanchang University300
已完成
4 期
Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)Atrial FibrillationNCT02100228Pfizer1,500
招募中
1 期
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant TumorsAdvanced Malignant NeoplasmAdvanced or Metastatic Non-small Cell Lung CancerNCT06581419SUNHO（China）BioPharmaceutical CO., Ltd.78